Publicaciones en las que colabora con María José Giménez Mestre (26)

2019

  1. Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains

    Journal of Global Antimicrobial Resistance, Vol. 19, pp. 241-251

2013

  1. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 10, pp. 2291-2295

  2. Protection of Enterococcus faecalis in mixed cultures with carbapenemase-producing Escherichia coli and Bacteroide fragilis: effect of the bacterial load.

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26, Núm. 3, pp. 220-225

2011

  1. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24 h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate- resistant Staphylococcus aureus

    International Journal of Antimicrobial Agents, Vol. 37, Núm. 4, pp. 332-338

  2. Efficacy of simulated cefditoren versus amoxicillin-clavulanate free concentrations in countering intrastrain ftsI gene diffusion in Haemophilus influenzae

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 6, pp. 2788-2794

2010

  1. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2 μg/mL

    International Journal of Antimicrobial Agents, Vol. 35, Núm. 2, pp. 131-137

  2. Cefditoren versus ceftazidime in inducersubstrate combinations for the evaluation of AmpC production in a disc approximation test

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 2, pp. 72-75

  3. Enhanced in vivo activity of cefditoren in preimmunized mice against penicillin-resistant S. pneumoniae (Serotypes 6B, 19F and 23F) in a sepsis model

    PLoS ONE, Vol. 5, Núm. 8

  4. Exposure-response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria

    International Journal of Antimicrobial Agents, Vol. 36, Núm. 2, pp. 137-144

  5. In vitro killing activity of crevicular concentrations of tinidazole plus common oral antibiotics against high-density mixed inocula of periodontal pathogens in strict anaerobic conditions

    Journal of Periodontology, Vol. 81, Núm. 1, pp. 131-138

  6. Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC

    Journal of Clinical Microbiology, Vol. 48, Núm. 6, pp. 2243-2246

2009

  1. In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 6

  2. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different β-lactams: An in vitro pharmacodynamic approach

    Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 6, pp. 1215-1222

  3. Tinidazole inhibitory and cidal activity against anaerobic periodontal pathogens

    International Journal of Antimicrobial Agents, Vol. 33, Núm. 5, pp. 449-452

2008

  1. Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Núm. 8, pp. 679-683

  2. Decrease in bacterial load versus resistance selection of pneumococcal subpopulations by β-lactam physiological concentrations over time: An in vitro pharmacodynamic simulation

    Microbial Drug Resistance, Vol. 14, Núm. 1, pp. 13-21

  3. High protein binding and cidal activity against penicillin-resistant S. pneumoniae: A cefditoren in vitro pharmacodynamic simulation

    PLoS ONE, Vol. 3, Núm. 7

  4. Urine bactericidal activity against Escherichia coli isolates exhibiting different resistance phenotypes/genotypes in an in vitro pharmacodynamic model simulating urine concentrations obtained after oral administration of a 400-milligram single dose of cefditoren-pivoxil

    Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 3, pp. 1184-1186

  5. β-Lactam effects on mixed cultures of common respiratory isolates as an approach to treatment effects on nasopharyngeal bacterial population dynamics

    PLoS ONE, Vol. 3, Núm. 12

  6. β-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: An in vitro pharmacodynamic simulation

    Chemotherapy, Vol. 54, Núm. 2, pp. 84-90